AU2022264844A1 - New formulation - Google Patents
New formulation Download PDFInfo
- Publication number
- AU2022264844A1 AU2022264844A1 AU2022264844A AU2022264844A AU2022264844A1 AU 2022264844 A1 AU2022264844 A1 AU 2022264844A1 AU 2022264844 A AU2022264844 A AU 2022264844A AU 2022264844 A AU2022264844 A AU 2022264844A AU 2022264844 A1 AU2022264844 A1 AU 2022264844A1
- Authority
- AU
- Australia
- Prior art keywords
- formulation
- mol
- content
- relative
- total weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Gynecology & Obstetrics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21305559 | 2021-04-30 | ||
| EP21305559.3 | 2021-04-30 | ||
| PCT/EP2022/061511 WO2022229402A1 (en) | 2021-04-30 | 2022-04-29 | New formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2022264844A1 true AU2022264844A1 (en) | 2023-11-23 |
Family
ID=75904839
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2022264844A Pending AU2022264844A1 (en) | 2021-04-30 | 2022-04-29 | New formulation |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240325294A1 (https=) |
| EP (1) | EP4329727A1 (https=) |
| JP (1) | JP2024516264A (https=) |
| KR (1) | KR20240006032A (https=) |
| CN (1) | CN117222402A (https=) |
| AU (1) | AU2022264844A1 (https=) |
| CA (1) | CA3217538A1 (https=) |
| MX (1) | MX2023012801A (https=) |
| WO (1) | WO2022229402A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026013080A1 (en) | 2024-07-08 | 2026-01-15 | InnoCore Technologies Holding B.V. | Pharmaceutical composition based on biodegradable polymers comprising polyoxazoline |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2741628B1 (fr) | 1995-11-29 | 1998-02-06 | Centre Nat Rech Scient | Nouveaux hydrogels a base de copolymeres trisequences et leur application notamment a la liberation progressive de principes actifs |
| US9023897B2 (en) * | 2010-12-29 | 2015-05-05 | Medincell | Biodegradable drug delivery compositions |
| CN103446043B (zh) * | 2012-05-29 | 2015-06-17 | 辽宁省计划生育科学研究院 | 一种原位凝胶注射植入剂 |
| EP2866837B1 (en) * | 2012-06-27 | 2022-12-14 | Medincell S.A. | Biodegradable drug delivery for hydrophobic compositions |
| US10188602B2 (en) * | 2016-09-29 | 2019-01-29 | Gesea Biosciences Inc. | Bioerodible implant for long-term drug delivery and associated methods of manufacture and use |
| EP3655017B1 (en) * | 2017-07-17 | 2025-01-22 | Medincell S.A. | Pharmaceutical composition |
| KR102441064B1 (ko) * | 2017-07-17 | 2022-09-06 | 현대자동차주식회사 | 연료전지 차량의 제어 방법 |
-
2022
- 2022-04-29 CN CN202280031387.XA patent/CN117222402A/zh active Pending
- 2022-04-29 CA CA3217538A patent/CA3217538A1/en active Pending
- 2022-04-29 US US18/557,882 patent/US20240325294A1/en active Pending
- 2022-04-29 KR KR1020237041232A patent/KR20240006032A/ko active Pending
- 2022-04-29 AU AU2022264844A patent/AU2022264844A1/en active Pending
- 2022-04-29 MX MX2023012801A patent/MX2023012801A/es unknown
- 2022-04-29 JP JP2023566975A patent/JP2024516264A/ja active Pending
- 2022-04-29 EP EP22726457.9A patent/EP4329727A1/en active Pending
- 2022-04-29 WO PCT/EP2022/061511 patent/WO2022229402A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| MX2023012801A (es) | 2023-11-08 |
| JP2024516264A (ja) | 2024-04-12 |
| WO2022229402A1 (en) | 2022-11-03 |
| EP4329727A1 (en) | 2024-03-06 |
| US20240325294A1 (en) | 2024-10-03 |
| CA3217538A1 (en) | 2022-11-03 |
| CN117222402A (zh) | 2023-12-12 |
| KR20240006032A (ko) | 2024-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102745079B1 (ko) | 약제학적 조성물 | |
| US20230146925A1 (en) | Depot formulations | |
| DE60318035T2 (de) | Polymermikroemulsionen | |
| AU2011350898B2 (en) | Biodegradable drug delivery compositions | |
| CN105163719B (zh) | 包含高粘度液体载体的可注射控制释放组合物 | |
| MX2014015902A (es) | Suministro de farmaco biodegradable para las composiciones hidrofobicas. | |
| US20240325294A1 (en) | Etonogestrel formulation | |
| US8084427B2 (en) | Subcutaneous implants containing a degradation-resistant polylactide polymer | |
| CN116262099B (zh) | 一种缓释温敏凝胶及其制备方法和其应用 | |
| JP2026502795A (ja) | 溶媒除去技術に基づく無菌in-situゲルの製造方法及びその製品 | |
| AU2013202476B2 (en) | Improved depot formulations | |
| Pharm | Fahad Pervaiz | |
| EA045044B1 (ru) | Смеси биоразлагаемых композиций для доставки лекарственных средств для модулирования кинетики высвобождения из лекарственного средства по меньшей мере одного активного ингредиента |